Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Molecular Diagnostics of Genetic Myopathy in Indian Subcontinent

ABSTRACT: Molecular Diagnostics of Genetic Myopathy in Indian Subcontinent using Exome sequencing

PROVIDER: PRJEB40370 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR4604780.fastq.gz	Fastqsanger.gz
	ERR4604790.fastq.gz	Fastqsanger.gz
	ERR4604781.fastq.gz	Fastqsanger.gz
	ERR4604791.fastq.gz	Fastqsanger.gz
	ERR4606491.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 29

Similar Datasets

Whole exome sequencing of Lung Squamous Carcinoma Patients of Indian Origin

Project description:The study involves whole exome sequencing of 20 primary tumors obtained from lung squamous carcinoma patients of Indian origin. With this, we aim to describe the mutational profile of this specific subset of lung cancer patients. This knowledge will further allow us to gain an insight into potentially actionable genomic alterations prevalent in Indian lung squamous carcinoma.

2022-02-11 | E-MTAB-8801 | biostudies-arrayexpress

Gene expression-based, molecular pathomechanism prediction for GNE myopathy III

Project description:Molecular impacts in the pathogenesis of GNE myopathy in model mouse muscles were well described through expression profiling of a total of 34000 genes

2017-07-01 | GSE95150 | GEO

Gene expression-based, molecular pathomechanism prediction for GNE myopathy II

Project description:Molecular impacts of 1% N-acetylcysteine treatment on GNE myopathy model mice were well described through expression profiling of a total of 34000 genes

2017-07-01 | GSE95149 | GEO

Gene expression-based, molecular pathomechanism prediction for GNE myopathy I

Project description:Molecular impacts of 0.1% N-acetylcysteine treatment on GNE myopathy model mice were well described through expression profiling of a total of 34000 genes

2017-07-01 | GSE95148 | GEO

TMC-SNPdb: An Indian germline variant dataset derived from whole exome sequence

Project description:Cancer is predominantly a somatic disease. A mutant allele found in cancer cell genome is considered somatic when it is absent in paired normal genome and dbSNP, the most comprehensive public SNP database. However, dbSNP inadequately represents several non-Caucasian populations including that from the Indian subcontinent, posing a limitation in cancer genomic analyses of data from these populations. We present TMC-SNPdb, as the first open source freely accessible (through ANNOVAR), flexible and upgradable SNP database from whole exome data of 62 normal samples derived from cancer patients of Indian origin, representing 114,309 unique germline variants. TMC-SNPdb is presented with a companion subtraction tool that can be executed with command line option or an easy-to-use graphical user interface (GUI) with the ability to deplete additional Indian population specific SNPs over and above that possible with dbSNP and 1000 Genomes databases. Using an institutional generated whole exome data set of 132 samples of Indian origin, we demonstrate that TMC-SNPdb reduced 42%, 33% and 28% false positive somatic events post dbSNP depletion in Indian origin tongue, gallbladder, and cervical cancer samples, respectively. Beyond cancer somatic analyses, we anticipate utility of TMC-SNPdb in several Mendelian germline diseases.

2018-06-06 | E-MTAB-4618 | biostudies-arrayexpress

Gene expression-based, molecular pathomechanism prediction for GNE myopathy

Project description:Gene expression-based, molecular pathomechanism prediction for GNE myopathy

| PRJNA376192 | ENA

Genetic Susceptibility to Statin-Induced Myopathy

Project description:Genetic Susceptibility to Statin-Induced Myopathy

| PRJNA381255 | ENA

Cellular and molecular alterations to muscles and neuromuscular synapses in Megf10-related myopathy

Project description:Loss-of-function mutations in MEGF10 lead to a rare and understudied neuromuscular disorder known as MEGF10-related myopathy. There are no treatments for the progressive respiratory distress, motor impairment, and structural abnormalities in muscles caused by the loss of MEGF10 function. In this study, we asked whether mice lacking MEGF10 (MEGF10 KO) could be used as a model to generate preclinical insights to treat MEGF10-related myopathy. We deployed cellular and molecular assays to examine juvenile, young adult, and middle-aged Megf10 constitutive knockout (KO) mice. We found fewer muscle fibers in developing and adult Megf10 KO mice, supporting published studies that MEGF10 regulates myogenesis by affecting satellite cell differentiation. Interestingly, muscle fibers do not exhibit morphological hallmarks of atrophy in either young adult or middle-aged Megf10 KO mice. We next examined the neuromuscular junction (NMJ), in which MEGF10 has been shown to concentrate postnatally, using light and electron microscopy. We found early and progressive degenerative features at the NMJs of Megf10 KO mice. These include increased postsynaptic fragmentation, axon terminals failing to completely appose the postsynaptic region and perisynaptic Schwann cells intruding into the NMJ synaptic cleft. These findings strongly suggest that the NMJ is a site of postnatal pathology in MEGF10-related myopathy. We next sought to identify molecular mechanisms altered in muscles lacking Megf10 using RNA-seq. We discovered genes and pathways associated with myogenesis, skeletal muscle health, and NMJ stability dysregulated in Megf10 KO mice compared to wild-type mice. Altogether, these data support using MEGF10 KO mice to discover and test potential treatments for MEGF10-related myopathy.

2024-02-20 | GSE256199 | GEO

Molecular Diagnostics in Sepsis: from Bedside to Bench

Project description:Molecular Diagnostics in Sepsis: from Bedside to Bench

| PRJNA96877 | ENA

Statin-induced Myopathy

Project description:We performed a genome-wide association study in pooled DNA samples from patients with severe statin myopathy and persistent symptoms post-therapy versus pooled DNAs from an age-adjusted statin-tolerant group. Affymetrix 100K SNP arrays were used according to the manufacturers instructions with two pools of 19 and 20 statin myopathy patients and two pools of 20 statin-tolerant controls.

2010-07-09 | E-GEOD-17574 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data